Basal Ganglia Pathophysiology

161 – 170 of 200

show: 10
|
sort: year (new to old)

News feed Embed this list Save this search Mark all Export

Cancel

Embed this list

copy and paste the html snippet below into your own page:

<iframe src="https://lup.lub.lu.se/search/organization/V1000356?embed=1&amp;hide_pagination=1&amp;hide_info=1&amp;hide_options=1"
  width="100%"
  height="400"
  allowtransparency="true"
  frameborder="0">
</iframe>

2006
Mark The impact of graft size on the development of dyskinesia following intrastriatal grafting of embryonic dopamine neurons in the rat.
Lane, Emma ^LU ; Winkler, C ; Brundin, Patrik ^LU and Cenci Nilsson, Angela ^LU (2006) In Neurobiology of Disease 22(2). p.334-345
- Contribution to journal › Article
Mark Verapamil prevents, in a dose-dependent way, the loss of ChAT-immunoreactive neurons in the cerebral cortex following lesions of the rat nucleus basalis magnocellularis
Popovic, M ; Caballero-Bleda, M ; Popovic, Natalija ^LU ; Puelles, L ; van Groen, T and Witter, MP (2006) In Experimental Brain Research 170(3). p.368-375
- Contribution to journal › Article
Mark Endothelial proliferation and increased blood-brain barrier permeability in the basal ganglia in a rat model of 3,4-dihydroxyphenyl-L-alanine-induced dyskinesia.
Westin, Jenny ^LU ; Lindgren, Hanna ^LU ; Gardi, Jonathan ; Nyengaard, Jens Randel ; Brundin, Patrik ^LU ; Mohapel, Paul ^LU and Cenci Nilsson, Angela ^LU (2006) In JNeurosci 26(37). p.9448-9461
- Contribution to journal › Article
Mark Role of striatal l-DOPA in the production of dyskinesia in 6-hydroxydopamine lesioned rats.
Carta, Manolo ^LU ; Lindgren, Hanna ^LU ; Lundblad, Martin ^LU ; Stancampiano, Roberto ; Fadda, Fabio and Cenci Nilsson, Angela ^LU (2006) In Journal of Neurochemistry 96(6). p.1718-1727
- Contribution to journal › Article
Mark Post- versus presynaptic plasticity in L-DOPA-induced dyskinesia.
Cenci Nilsson, Angela ^LU and Lundblad, Martin ^LU (2006) In Journal of Neurochemistry 99(2). p.381-392
- Contribution to journal › Article
Mark Mechanisms of L-DOPA-induced dyskinesia in Parkinson´s disease: What do animal models tell us?
Cenci Nilsson, Angela ^LU (2006) p.351-360
- Chapter in Book/Report/Conference proceeding › Book chapter
Mark Dyskinesia and neural grafting in Parkinson's disease
Cenci Nilsson, Angela ^LU and Hagell, Peter ^LU (2006) p.184-224
- Chapter in Book/Report/Conference proceeding › Book chapter
2005
Mark Pharmacological validation of a mouse model of l-DOPA-induced dyskinesia.
Lundblad, Martin ^LU ; Usiello, A ; Carta, Manolo ^LU ; Håkansson, Katarina ; Fisone, G and Cenci Nilsson, Angela ^LU (2005) In Experimental Neurology 194(1). p.66-75
- Contribution to journal › Article
Mark Orexin loss in Huntington's disease.
Petersén, Åsa ^LU ; Gil, Joana ^LU ; Maat-Schieman, Marion L C ; Björkqvist, Maria ^LU ; Tanila, Heikki ; Araújo, Ines M ; Smith, Ruben ^LU ; Popovic, Natalija ^LU ; Wierup, Nils ^LU and Norlén, Per ^LU , et al. (2005) In Human Molecular Genetics 14(1). p.39-47
- Contribution to journal › Article
Mark The R6/2 transgenic mouse model of Huntington's disease develops diabetes due to deficient {beta}-cell mass and exocytosis.
Björkqvist, Maria ^LU ; Fex, Malin ^LU ; Renström, Erik ^LU ; Wierup, Nils ^LU ; Petersén, Åsa ^LU ; Gil, Joana ^LU ; Bacos, Karl ^LU ; Popovic, Natalija ^LU ; Li, Jia-Yi ^LU and Sundler, Frank ^LU , et al. (2005) In Human Molecular Genetics 14(5). p.565-574
- Contribution to journal › Article